Rybelsus real-world vs clinical trial efficacy — the gap explained

sarah_TO said:

It is worth asking what the claim would look like if it were false.

Can confirm. Same sequence, different timescale.

josh_phd_bmore said:

If you are going to change something, change one thing and give it long enough to express itself.

Adding the part of the answer the thread has not reached. The gap between trial results and real-world results is consistent and it is not fraud. Trial participants get titration by protocol, scheduled contact, free drug and dietetic support; removing that infrastructure costs a few percentage points every time it has been measured. When your own curve sits below the published mean, that is the likeliest explanation before anything about you or your material.

One concrete data point for the thread. One habit that pays for itself: post the method alongside the number. A figure without its method cannot be checked, and an unchecked figure is how this community accumulates folklore.

A narrower follow-up, since the general answer is now clear:

How to read a result like this without either dismissing it or over-reading it, since the summaries all read like press releases?

Moderator note: good thread. Keeping it here rather than moving it, because the question is general enough to be useful.